{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:56:37Z","timestamp":1784120197625,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.amjcard.2016.06.023","type":"journal-article","created":{"date-parts":[[2016,6,19]],"date-time":"2016-06-19T05:14:34Z","timestamp":1466313274000},"page":"673-678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Oxidized Low-Density Lipoprotein-\u03b22-Glycoprotein I Complex But Not Free Oxidized LDL Is Associated With the Presence and Severity of Coronary Artery Disease"],"prefix":"10.1016","volume":"118","clinical-trial-number":[{"clinical-trial-number":"nct01276678","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Kevin P.","family":"Bliden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis R.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongras","family":"Damrongwatanasuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk","family":"Guyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Gesheff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himabindu","family":"Kaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya S.","family":"Tantry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Gurbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2016.06.023_bib1","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/heart.89.11.1288","article-title":"C\u00a0reactive protein for risk stratification in acute coronary syndromes? Verdict: unproven","volume":"89","author":"Kennon","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2016.06.023_bib2","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","article-title":"Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group","volume":"343","author":"Packard","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.06.023_bib3","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/archinte.166.13.1368","article-title":"An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study","volume":"166","author":"Folsom","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2016.06.023_bib4","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1111\/j.1541-9215.2006.05524.x","article-title":"The future of cardiovascular biomarkers","volume":"4","author":"Rodgers","year":"2006","journal-title":"Am Heart Hosp J"},{"key":"10.1016\/j.amjcard.2016.06.023_bib5","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/archinte.166.13.1342","article-title":"Predicting cardiovascular risk: so what do we do now?","volume":"166","author":"Lloyd-Jones","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2016.06.023_bib6","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1056\/NEJMe0801721","article-title":"Multiple biomarker panels for cardiovascular risk assessment","volume":"358","author":"de Lemos","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.06.023_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.amjmed.2007.06.030","article-title":"Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study","volume":"121","author":"Shlipak","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2016.06.023_bib8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.06.023_bib9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.ATV.10.4.520","article-title":"Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia","volume":"10","author":"Austin","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.amjcard.2016.06.023_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/10446670410001722186","article-title":"Are oxidized LDL\/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?","volume":"11","author":"Matsuura","year":"2004","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.amjcard.2016.06.023_bib11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1191\/0961203306lu2267oa","article-title":"Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis","volume":"15","author":"Lopez","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.amjcard.2016.06.023_bib12","first-page":"234316","article-title":"Proatherogenic oxidized low-density lipoprotein\/beta2-glycoprotein I complexes in arterial and venous disease","volume":"2014","author":"Berger","year":"2014","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.amjcard.2016.06.023_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1309\/AJCP2FJUT2YZGITK","article-title":"Newer antiphospholipid antibodies predict adverse outcomes in patients with acute coronary syndrome","volume":"132","author":"Greco","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.amjcard.2016.06.023_bib14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1309\/AJCP88WVRDRDFBAS","article-title":"Oxidized-LDL\/beta(2)-glycoprotein I complexes are associated with disease severity and increased risk for adverse outcomes in patients with acute coronary syndromes","volume":"133","author":"Greco","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.amjcard.2016.06.023_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.atherosclerosis.2014.01.034","article-title":"Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease","volume":"233","author":"Williams","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2016.06.023_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/1474651410388057","article-title":"Rosuvastatin treatment is associated with a decrease of serum oxidised low-density lipoprotein\/beta2-glycoprotein i complex concentration in type 2 diabetes","volume":"10","author":"Ames","year":"2010","journal-title":"Br J Diabetes Vasc Dis"},{"key":"10.1016\/j.amjcard.2016.06.023_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1476-511X-13-111","article-title":"Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction","volume":"13","author":"Gruzdeva","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.amjcard.2016.06.023_bib18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12265-013-9468-x","article-title":"Association of biomarkers of lipid modification with functional and morphological indices of coronary stenosis severity in stable coronary artery disease","volume":"6","author":"Muller","year":"2013","journal-title":"J\u00a0Cardiovasc Transl Res"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916310451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916310451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T04:24:15Z","timestamp":1536639855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914916310451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0002914916310451"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.06.023","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidized Low-Density Lipoprotein-\u03b22-Glycoprotein I Complex But Not Free Oxidized LDL Is Associated With the Presence and Severity of Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}